Nuzenio

Launches Phase Iib

Launches Phase Iib news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

event 4 latest news signals 3 publisher sources 100/100 entity strength

Latest news

NeuroThera Launches Phase IIb Trial at Yale for Novel Tourette Treatment - citybuzz -citybuzz - · Thu, 06 Aug 2026 00:24:05 GMTSciSparc (Nasdaq: SPRC) launches Phase IIb SCI-110 Tourette study - Stock TitanStock Titan · Wed, 05 Aug 2026 13:00:51 GMTSciSparc: Subsidiary NeuroThera Labs Launches Phase IIb - GlobeNewswireGlobeNewswire · Wed, 05 Aug 2026 12:22:00 GMTTourette drug candidate enters Phase IIb with prior 21% tic reduction - Stock TitanStock Titan · Wed, 05 Aug 2026 12:22:00 GMT

Timeline

Thu, 06 Aug 2026 00:24:05 GMTNeuroThera Launches Phase IIb Trial at Yale for Novel Tourette Treatment - citybuzz -
Wed, 05 Aug 2026 13:00:51 GMTSciSparc (Nasdaq: SPRC) launches Phase IIb SCI-110 Tourette study - Stock Titan
Wed, 05 Aug 2026 12:22:00 GMTSciSparc: Subsidiary NeuroThera Labs Launches Phase IIb - GlobeNewswire
Wed, 05 Aug 2026 12:22:00 GMTTourette drug candidate enters Phase IIb with prior 21% tic reduction - Stock Titan

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Launches Phase Iib.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

3 distinct publisher/source names are currently connected to this entity page.